Nikki Schultek

Nikki received her BS in Business Administration from Villanova University, studying Marketing, French and International Business. She began her career in industry with Pfizer and Genentech. Shortly after accepting her most treasured role, “mom”, Nikki fell systemically ill, including frightening neurodegenerative symptoms. After being diagnosed with Lyme Disease, Chlamydia pneumoniae and other co-infections and receiving antibiotic therapy, she experienced remission. Nikki is accelerating innovation in IACCIs, such as Alzheimer’s Disease, Asthma, and others by building interdisciplinary research collaborations. In 2017 she Founded Intracell Research Group, LLC, to unite researchers, clinicians, and stakeholders across the globe. Nikki also serves as a co-investigator of a, 3,200-patient asthma trial (iTREAT-PC), Guest Editor of a special issue on infections for the Springer Nature Journal "Molecular Neurobiology", Co-Founder and Executive Director of The Alzheimer’s Pathobiome Initiative, and President of the new CureChronic Disease Foundation, Inc. (501c3 pending).